Add Formweb to your mobile device
Search results for:
letermovir
letermovir
- Restricted: Restricted to inpatient use only for CMV prophylaxis in allogeneic stem cell transplant patients (CMV recipient positive and/or donor positive). IV formulation further restricted to patients who are NPO.
Brand names: Prevymis
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, INTRAVENOUS | 240 mg/12 mL; 480 mg/24 mL | Restricted | ||||||||||
| TABLET, ORAL | 240 mg; 480 mg | Restricted |
Last updated: Dec. 9, 2024
Order alert: Patient to bring PO home medication supply when available. Oral used except when patient is NPO.